Previous 10 |
LEXINGTON, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced fi...
The first quarter of 2019 was robust with activity for the biotechnology industry thanks to merger and acquisitions (M&A) in addition to initial public offerings (IPOs). Looking back to the end of last year, the biotech sector took a significant hit in terms of stock performance, ...
Preclinical tests assessing Kaleido Biosciences' (NASDAQ: KLDO ) Microbiome Metabolic Therapy (MMT) candidate KB195 showed its ability to reduce ammonia in healthy human microbiome samples. The results were presented at The International Liver Congress in Vienna. More news on: Kaleido B...
LEXINGTON, Mass., April 12, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today presen...
LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc . (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announ...
News, Short Squeeze, Breakout and More Instantly...
Kaleido Biosciences Inc. Company Name:
KLDO Stock Symbol:
NYSE Market:
Kaleido Biosciences Inc. Website:
What to Know About Buying Penny Stocks on April 14th, 2022 With another day of trading penny stocks here, there is a lot for investors to consider. Right now, the biggest news came as Elon Musk offered to buy 100% of Twitter Inc. ( NYSE: TWTR ) for $54 per share. Currently, the Tesl...